Waldencast
Holding Companies & Conglomerates · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Michelin House 81 Fulham Rd, London, Gre...Phone Number
+44 9175466828Website
www.waldencast.comRevenue
$272.1 MillionStock Symbol
WALDIndustry
About Waldencast
Waldencast Org Chart
Is Waldencast your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Waldencast had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Waldencast has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Waldencast launches new products
Earning: See what the market has to say on Waldencast recently announced quarterly report
Funding: Get notified immidiatlly once Waldencast has new funding data
Check out if Waldencast is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Waldencast, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Waldencast
Recommended Actions
Find VP level buyers at Waldencast
Find 3 more new buyers
Compare Similar Companies to Waldencast
Compare insights from companies similar to Waldencast, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Waldencast is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Waldencast is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Waldencast.
Waldencast Tech Stack
A closer look at the technologies used by Waldencast
Most Recent Scoops
Waldencast News & Media
Waldencast Announces Sale of Obagi Medical to Bridgepoint
LONDON, June 01, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Company”) today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business (“Obagi Medical”) to Bridgepoint, one of the world's leading mid-market investors, in a transaction valued at up to $460 million, marking a significant step in Waldencast’s strategy to strengthen its balance sheet and focus on accelerating the global growthObagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice SuccessObagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation A multi-city pop-up introducing consumers to the future of skincare and longevity innovationObagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Waldencast
Waldencast is a beauty brand platform and operating company focused on acquiring, nurturing, and scaling independent beauty and wellness brands while preserving each brands identity and entrepreneurial culture. Through its model, the company supports growth, brand building, and strategic development across its portfolio, with an emphasis on sustain... Read More